BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17921793)

  • 1. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women.
    Fernández M; Calvo-Alén J; Bertoli AM; Bastian HM; Fessler BJ; McGwin G; Reveille JD; Vilá LM; Alarcón GS
    J Clin Rheumatol; 2007 Oct; 13(5):261-5. PubMed ID: 17921793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
    Fernández M; Calvo-Alén J; Alarcón GS; Roseman JM; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Sanchez ML; Reveille JD
    Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients.
    Calvo-Alén J; Toloza SM; Fernández M; Bastian HM; Fessler BJ; Roseman JM; McGwin G; Vilá LM; Reveille JD; Alarcón GS;
    Arthritis Rheum; 2005 Jul; 52(7):2060-8. PubMed ID: 15986376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.
    Toloza SM; Uribe AG; McGwin G; Alarcón GS; Fessler BJ; Bastian HM; Vilá LM; Wu R; Shoenfeld Y; Roseman JM; Reveille JD;
    Arthritis Rheum; 2004 Dec; 50(12):3947-57. PubMed ID: 15593203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events.
    Szalai AJ; Alarcón GS; Calvo-Alén J; Toloza SM; McCrory MA; Edberg JC; McGwin G; Bastian HM; Fessler BJ; Vilá LM; Kimberly RP; Reveille JD
    Rheumatology (Oxford); 2005 Jul; 44(7):864-8. PubMed ID: 15797975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events.
    Ho KT; Ahn CW; Alarcón GS; Baethge BA; Tan FK; Roseman J; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Calvo-Alén J; Reveille JD
    Rheumatology (Oxford); 2005 Oct; 44(10):1303-7. PubMed ID: 16030085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.
    Buyon JP; Petri MA; Kim MY; Kalunian KC; Grossman J; Hahn BH; Merrill JT; Sammaritano L; Lockshin M; Alarcón GS; Manzi S; Belmont HM; Askanase AD; Sigler L; Dooley MA; Von Feldt J; McCune WJ; Friedman A; Wachs J; Cronin M; Hearth-Holmes M; Tan M; Licciardi F
    Ann Intern Med; 2005 Jun; 142(12 Pt 1):953-62. PubMed ID: 15968009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII).
    Burgos PI; McGwin G; Reveille JD; Vilá LM; Alarcón GS
    Rheumatology (Oxford); 2010 Sep; 49(9):1720-5. PubMed ID: 20498010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage.
    Toloza SM; Roseman JM; Alarcón GS; McGwin G; Uribe AG; Fessler BJ; Bastian HM; Vilá LM; Reveille JD
    Arthritis Rheum; 2004 Oct; 50(10):3177-86. PubMed ID: 15476246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.
    Hochman J; Urowitz MB; Ibañez D; Gladman DD
    Lupus; 2009 Apr; 18(4):313-7. PubMed ID: 19276299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE).
    Arden NK; Lloyd ME; Spector TD; Hughes GR
    Lupus; 1994 Feb; 3(1):11-3. PubMed ID: 8025579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.
    Tkachenko O; Lapin S; Mazing A; Emanuel V; Belolipetskaia E; Beliaeva I; Myachikova V; Maslyansky A; Schierack P; Roggenbuck D
    Lupus; 2020 Apr; 29(5):490-498. PubMed ID: 32131675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus.
    Mok CC; Lau CS; Ho CT; Lee KW; Mok MY; Wong RW
    Scand J Rheumatol; 1998; 27(5):342-6. PubMed ID: 9808396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events.
    Calvo-Alén J; Alarcón GS; Tew MB; Tan FK; McGwin G; Fessler BJ; Vilá LM; Reveille JD;
    Arthritis Rheum; 2006 Jun; 54(6):1940-5. PubMed ID: 16729310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone replacement therapy and venous thromboembolism.
    Wu O
    Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus and hormone replacement therapy.
    Gompel A; Piette JC
    Menopause Int; 2007 Jun; 13(2):65-70. PubMed ID: 17540136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage.
    Bertoli AM; Vila LM; Apte M; Fessler BJ; Bastian HM; Reveille JD; Alarcon GS;
    Lupus; 2007; 16(6):410-7. PubMed ID: 17664231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV).
    Andrade RM; Alarcón GS; González LA; Fernández M; Apte M; Vilá LM; McGwin G; Reveille JD;
    Ann Rheum Dis; 2008 Jun; 67(6):829-34. PubMed ID: 17875548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX).
    Burgos PI; Vilá LM; Reveille JD; Alarcón GS
    Lupus; 2009 Dec; 18(14):1303-8. PubMed ID: 19850658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.